Abstract
Introduction: Plasma cell leukaemia (PCL) is a rare blood disorder with an aggressive clinical course and dismal diagnosis. PCL is diagnosed based on the presence of an absolute plasma count of more than 2×109/L or 20% plasma cells in the peripheral blood. Initial presentation (primary PCL, pPCL) is 2–4% of myelomas. Secondary PCL is a leukaemic transformation occurring in approximately 1% of previously diagnosed plasma cell myeloma. The incidence of PCL is low, and this case presents a rare opportunity to describe the clinical and pathological characteristics of this disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.